AHA GUIDELINES Bundle (free trial)

Management of Adults With Congenital Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1541979

Contents of this Issue

Navigation

Page 93 of 93

Disclaimer is resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers aer consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary. Source Gurvitz M, Krieger EV, Fuller S, Davis LL, Kittleson MM, Aboulhosn JA, Bradley EA, Buber J, Daniels CJ, Dimopoulos K, Egbe A, Geoffrion TR, John A, Khairy P, Kim YY, Kreutzer J, Lewis MJ, Menachem JN, Moore JP, Osteen KA, Parikh PB, Saidi A, Salciccioli KB, Schunder RL, Valente AM, Wald RM. 2025 ACC/AHA/HRS/ISACHD/SCAI guideline for the management of adults with congenital heart disease: a report of the American College of Cardiolog y/American Heart Association Joint Committee on Clinical Practice Guidelines [published online ahead of print Dec 18, 2025]. J Am Coll Cardiol. doi: 10.1016/j.jacc.2025.09.006. Copublished in Circulation. doi: 10.1161/CIR.0000000000001402. AHACAH11253 TEL: 407.878.7606 Order additional copies at GuidelineCentral.com Copyright © 2025 All rights reserved GuidelineCentral.com Abbreviations ΔP, peak pressure gradient; 6MWD, 6-minute walk distance; AAOCA, anomalous aortic origin of a coronary artery; ACC, American College of Cardiology; ACHD, adult congenital heart disease; AHA, American Heart Association; CT, computed tomography; AP, anatomic and physiological; APVC, anomalous pulmonary venous connection; ASD, atrial septal defect; AVSD, atrioventricular septal defect; BAV, bicuspid aortic valve; BNP, B-type natriuretic peptide; CCTGA, congenitally corrected transposition of the great arteries; CHEST, American College of Chest Physicians; CMR, cardiovascular magnetic resonance; COA, coarctation of the aorta; CPET, cardiopulmonary exercise testing; CRT, cardiac resynchronization therapy; CT, computed tomography; CTA, computed tomography angiography; DCRV, double-chambered right ventricle; d-TGA, dextro-transposition of the great arteries; EF, ejection fraction; ERS, European Respiratory Society; ESC, European Society of Cardiology; ESVi, end-systolic volume index; FALD, Fontan-associated liver disease; GDMT, guideline-directed medical therapy; HFSA, Heart Failure Society of America; HLHS, hypoplastic le heart syndrome; HRS, Heart Rhythm Society; ICD, implantable cardioverter-defibrillator; ISACHD, International Society for Adult Congenital Heart Disease; IVS, interventricular septum; JVD, jugular venous distention; LGE, late gadolinium enhancement; LV, le ventricular; LVEDV, le ventricular end-diastolic volume; LVEF, le ventricular ejection fraction; LVOT, le ventricular outflow tract; MCS, mechanical circulatory support; MIG, maximum instantaneous gradient; MR, magnetic resonance; mPAP, mean pulmonary artery pressure; MR, magnetic resonance; N/A, not applicable; NLA, National Lipid Association; NT-proBNP, N-terminal prohormone of B-type natriuretic peptide; NYHA, New York Heart Association; PA, pulmonary artery; PAH, pulmonary arterial hypertension; PA-IVS, pulmonary atresia with intact ventricular septum; PCNA, Preventive Cardiovascular Nurses Association; PCWP, pulmonary capillary wedge pressure; PDA, patent ductus arteriosus; PH, pulmonary hypertension; PR, pulmonary regurgitation; PS, pulmonary stenosis; PVR, pulmonary vascular resistance; Qp:Qs, pulmonary-to-systemic blood flow ratio; RAE, right atrial enlargement; RF, regurgitant fraction; RV, right ventricle; RVE, right ventricular enlargement; RVEDV, right ventricular end-diastolic volume; RVEF, right ventricular ejection fraction; RVOT, right ventricular outflow tract; RVOTO, right ventricular outflow tract obstruction; RVSP, right ventricular systolic pressure; RV-to-PA, right ventricle-to- pulmonary artery; SAEM, Society for Academic Emergency Medicine; SCAI, Society for Cardiovascular Angiography Interventions; SCCT, Society of Cardiovascular Computed Tomography; SCD, sudden cardiac death; SCMR, Society for Cardiovascular Magnetic Resonance; SVASD, sinus venosus atrial septal defect; SVR, systemic vascular resistance; TAPSE, tricuspid annular plane systolic excursion; TOF, tetralogy of Fallot; VF, ventricular fibrillation; Vmax, maximum velocity; VSD, ventricular septal defect

Articles in this issue

Links on this page

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Management of Adults With Congenital Heart Disease